牙科患者对牙科场所内HPV疫苗讨论与接种的认知:系统综述
该研究系统检索了2006年至2025年的定量与定性研究,共纳入14项牙科场所中患者认知研究。多数患者愿意与牙科专业人员讨论HPV疫苗及头颈癌,但大多数未在就诊时获得此类信息,且偏好牙医而非洁牙师提供讨论与接种。
要点
- 牙科患者对HPV疫苗讨论持接受态度,偏好牙医而非洁牙师。
- 多数患者未在牙科就诊时获得HPV或头颈癌相关信息。
- 患者接受在牙科场所为子女接种HPV疫苗,偏好牙医作为接种者。
核心结论
- 牙科患者普遍对在牙科场所讨论HPV疫苗持舒适和接受态度。
- 需要制定量身定制的循证策略以促进牙科场所HPV疫苗接种。
研究设计与样本
- 系统综述,检索PubMed/MEDLINE、Embase和Scopus,纳入2006年1月1日至2025年7月31日的英文同行评议文献。
- 纳入14项在牙科场所开展的定量或定性研究,其中5项关注成年患者、8项关注儿童患者父母、1项关注大学生患者。
主要发现
- 基于9项研究,23%至86%的患者对与牙科专业人员讨论HPV、HPV疫苗及头颈癌感到舒适或接受。
- 大多数患者(61%至93%)在牙科就诊时未收到此类信息。
- 患者偏好牙医而非洁牙师进行HPV相关讨论。
- 患者接受在牙科场所为子女接种HPV疫苗,并偏好牙医作为接种者。
- 来自牙科专业人员的咨询和信息可提高患者在牙科场所接种HPV疫苗的舒适度。
关键数值与推荐
- 14项研究中12项(85.7%)偏倚风险低,2项为中等风险。
- 系统综述遵循PRISMA指南,注册于PROSPERO(CRD42024585928)。
- 初始检索识别3213条记录,去除2802条重复后411条进行标题摘要筛选,45篇全文评估,最终纳入14项研究。
临床怎么用
- 牙科专业人员可在临床中主动与患者讨论HPV与口咽癌预防及HPV疫苗接种。
- 可考虑由牙医而非洁牙师主导HPV疫苗相关咨询与接种推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVE: The dental office is a critical frontline for preventing human papillomavirus (HPV)-related oropharyngeal cancer (OPC), as dentists are trusted primary oral health providers who can advise on this major cancer risk. This systematic review assessed dental patients' perceptions of HPV vaccine discussion and administration by dental professionals. METHODS: We searched PubMed/MEDLINE, Embase, and Scopus for peer-reviewed English-language publications from 1 January 2006 to 31 July 2025, with an updated search conducted on 1 September 2025. We included quantitative and qualitative studies conducted in dental settings that reported patients' perceptions of HPV, and the discussion and administration of vaccination. We assessed the potential bias of the reviewed quantitative studies using the Risk of Bias Tool. This review followed PRISMA guidelines and was registered with PROSPERO (CRD42024585928). RESULTS: Initial searches identified 3213 records. After removing 2802 duplicates, 411 records underwent title and abstract screening, 45 full-texts were assessed, and 14 studies were included. Of these, 5 focused on adult patients, 8 on parents of child patients, and 1 on college-aged student patients. Most studies (12/14, 85.7%) had a low risk of bias, while two had a moderate risk. A significant proportion (ranging from 23% to 86%, based on 9 studies) of patients reported feeling comfortable or receptive to discussing HPV, HPV vaccination, and head and neck cancers with dental professionals, preferring dentists over dental hygienists. However, most (61% to 93%) patients did not receive such information during dental visits. Patients were also receptive to vaccinating their children in dental settings and preferred dentists as vaccine administrators. Counselling and information from dental professionals increased patients' comfort in receiving HPV vaccination in these settings. CONCLUSIONS: Our findings show that dental patients are generally comfortable and receptive to HPV vaccination discussions in dental settings. Developing tailored, evidence-based strategies to promote HPV vaccination is warranted.
引用
- Mak TS, Chan KS, Yu OY, et al. HPV vaccine discussion and administration in dental primary healthcare settings for oropharyngeal cancer prevention: A systematic review from dental patients' perspectives. Vaccine. 2026. PMID: 41707513. doi:10.1016/j.vaccine.2026.128335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。